Outcomes with pembrolizumab (pembro) monotherapy in patients (pts) with PD-L1–positive NSCLC with brain metastases: Pooled analysis of KEYNOTE-001, -010, -024, and -042

Aaron S. Mansfield, Roy S. Herbst, Gilberto de Castro, Rina Hui, Nir Peled, D.-w. Kim, Silvia Novello, Miyako Satouchi, Yi‐Long Wu, Edward B. Garon, Martin Reck, Andrew Robinson, Ayman Samkari, Bilal Piperdi, Victoria Ebiana, J. Lin, Tony MokAnnals 2019 · DOI

BibTeX
@article{mansfield2019outcomes,
  author = {Aaron S. Mansfield and Roy S. Herbst and Gilberto de Castro and Rina Hui and Nir Peled and D.-W. Kim and Silvia Novello and Miyako Satouchi and Yi‐Long Wu and Edward B. Garon and Martin Reck and Andrew Robinson and Ayman Samkari and Bilal Piperdi and Victoria Ebiana and J. Lin and Tony Mok},
  title = {{Outcomes with pembrolizumab (pembro) monotherapy in patients (pts) with PD-L1–positive NSCLC with brain metastases: Pooled analysis of KEYNOTE-001, -010, -024, and -042}},
  journal = {Annals},
  year = {2019},
  doi = {10.1093/annonc/mdz260.004},
}

Loading related content...

Figure